Market Reports on China presents the report, on “China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022”. China’s quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer.

China In-Vitro Diagnostics (IVD) market is likely to more than triple by 2022 from its current level in 2016. China represents one of the largest clinical laboratory markets in the Asia-Pacific region, and the fastest growing among the top ten IVD country markets. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China IVD market is slated to show substantial growth in the future. China’s quickly aging population means the country is experiencing an explosion of chronic conditions such as diabetes, heart disease and cancer. All of these conditions can be diagnosed and monitored using IVD products. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future.

China IVD Market Segment Wise Analysis: Immunoassay is the leading segment in China IVD market. Immunoassay is likely to maintain its dominant position in the forecasting period as well. Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing. SMBG market accounted for XXX percent market share in 2016. Microbiology and Hematology segments are competing closely with each other to grab maximum share of the pie.

China IVD Market Company Analysis: In China IVD market, Roche Diagnostics is the leader with XXX percent market share in 2016. Sysmex Corporation and Mindary Medical are other top two players in the China IVD market. At present, many local players are present in China IVD market and their combined market share was XXX percent in 2016.

This is the 2nd edition report on China IVD Market by The report titled “China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022” studies in detail the China IVD Market - Application Segment Wise, Company Sales, Registration & Regulatory Status in China IVD & Driving Factors and Challenges for China IVD Market.

Table of Contents

1. China IVD Market and Market Share Analysis (2007 - 2022)

China IVD Market and Forecast
China IVD Market Share and Forecast
China IVD Company Share and Forecast

2. China IVD - Segments Wise Market and Forecast (2007 - 2022)

China Clinical Chemistry Market and Forecast
China Immunoassay Market and Forecast
China Hematology Market and Forecast
China Coagulation Market and Forecast
China Microbiology Market and Forecast
China Molecular Testing Market and Forecast
China Self Monitoring of Blood Glucose (SMBG) Market and Forecast
China Point of Care Testing (POCT) Market and Forecast

For More Information Kindly Visit: http://www.marketreportsonchina.com/life-sciences-market-research-reports-26520/china-in-vitro-diagnostics-analysis.html

Related Reports: http://www.marketreportsonchina.com/market-research-report/life-sciences.html?q=Diagnostics&ipage=&sortby=dd

Contact Us
Market Reports on China
Contact No: India: +91 22 27810773
Email: [email protected]
Website: http://www.marketreportsonchina.com
Twitter: https://twitter.com/ReportsonChina